427 related articles for article (PubMed ID: 24043758)
1. p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells.
Iannello A; Thompson TW; Ardolino M; Lowe SW; Raulet DH
J Exp Med; 2013 Sep; 210(10):2057-69. PubMed ID: 24043758
[TBL] [Abstract][Full Text] [Related]
2. Immune surveillance of unhealthy cells by natural killer cells.
Iannello A; Raulet DH
Cold Spring Harb Symp Quant Biol; 2013; 78():249-57. PubMed ID: 24135717
[TBL] [Abstract][Full Text] [Related]
3. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
Textor S; Fiegler N; Arnold A; Porgador A; Hofmann TG; Cerwenka A
Cancer Res; 2011 Sep; 71(18):5998-6009. PubMed ID: 21764762
[TBL] [Abstract][Full Text] [Related]
4. Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors.
Veneziani I; Infante P; Ferretti E; Melaiu O; Battistelli C; Lucarini V; Compagnone M; Nicoletti C; Castellano A; Petrini S; Ognibene M; Pezzolo A; Di Marcotullio L; Bei R; Moretta L; Pistoia V; Fruci D; Barnaba V; Locatelli F; Cifaldi L
Cancer Immunol Res; 2021 Feb; 9(2):170-183. PubMed ID: 33303573
[TBL] [Abstract][Full Text] [Related]
5. "Acquired" NKG2D Ligand Stimulates NK Cell-mediated Tumor Immunosurveillance.
Wang D; Gu X; Liu X; Liu X; Wang B; Lao F; Fang M
J Immunother; 2019; 42(6):189-196. PubMed ID: 31145234
[TBL] [Abstract][Full Text] [Related]
6. NKG2D ligands mediate immunosurveillance of senescent cells.
Sagiv A; Burton DG; Moshayev Z; Vadai E; Wensveen F; Ben-Dor S; Golani O; Polic B; Krizhanovsky V
Aging (Albany NY); 2016 Feb; 8(2):328-44. PubMed ID: 26878797
[TBL] [Abstract][Full Text] [Related]
7. Induction of NKG2D ligands and increased sensitivity of tumor cells to NK cell-mediated cytotoxicity by hematoporphyrin-based photodynamic therapy.
Park MJ; Bae JH; Chung JS; Kim SH; Kang CD
Immunol Invest; 2011; 40(4):367-82. PubMed ID: 21314289
[TBL] [Abstract][Full Text] [Related]
8. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells.
Tu MM; Mahmoud AB; Wight A; Mottashed A; Bélanger S; Rahim MM; Abou-Samra E; Makrigiannis AP
Cancer Res; 2014 Jul; 74(14):3684-94. PubMed ID: 24802191
[TBL] [Abstract][Full Text] [Related]
9. NK cells use NKG2D to recognize a mouse renal cancer (Renca), yet require intercellular adhesion molecule-1 expression on the tumor cells for optimal perforin-dependent effector function.
Abdool K; Cretney E; Brooks AD; Kelly JM; Swann J; Shanker A; Bere EW; Yokoyama WM; Ortaldo JR; Smyth MJ; Sayers TJ
J Immunol; 2006 Aug; 177(4):2575-83. PubMed ID: 16888019
[TBL] [Abstract][Full Text] [Related]
10. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
Doubrovina ES; Doubrovin MM; Vider E; Sisson RB; O'Reilly RJ; Dupont B; Vyas YM
J Immunol; 2003 Dec; 171(12):6891-9. PubMed ID: 14662896
[TBL] [Abstract][Full Text] [Related]
11. Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide.
Kim JY; Bae JH; Lee SH; Lee EY; Chung BS; Kim SH; Kang CD
J Immunother; 2008 Jun; 31(5):475-86. PubMed ID: 18463537
[TBL] [Abstract][Full Text] [Related]
12. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin.
Pende D; Cantoni C; Rivera P; Vitale M; Castriconi R; Marcenaro S; Nanni M; Biassoni R; Bottino C; Moretta A; Moretta L
Eur J Immunol; 2001 Apr; 31(4):1076-86. PubMed ID: 11298332
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2.
Li H; Lakshmikanth T; Garofalo C; Enge M; Spinnler C; Anichini A; Szekely L; Kärre K; Carbone E; Selivanova G
Cell Cycle; 2011 Oct; 10(19):3346-58. PubMed ID: 21941086
[TBL] [Abstract][Full Text] [Related]
14. NKG2D Ligand Shedding in Response to Stress: Role of ADAM10.
Zingoni A; Vulpis E; Loconte L; Santoni A
Front Immunol; 2020; 11():447. PubMed ID: 32269567
[TBL] [Abstract][Full Text] [Related]
15. Fratricide of natural killer cells dressed with tumor-derived NKG2D ligand.
Nakamura K; Nakayama M; Kawano M; Amagai R; Ishii T; Harigae H; Ogasawara K
Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9421-6. PubMed ID: 23690625
[TBL] [Abstract][Full Text] [Related]
16. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD
Front Immunol; 2020; 11():40. PubMed ID: 32082316
[TBL] [Abstract][Full Text] [Related]
17. p53 missense mutant G242A subverts natural killer cells in sheltering mouse breast cancer cells against immune rejection.
Uddin MB; Roy KR; Hill RA; Roy SC; Gu X; Li L; Zhang QJ; You Z; Liu YY
Exp Cell Res; 2022 Aug; 417(1):113210. PubMed ID: 35597298
[TBL] [Abstract][Full Text] [Related]
18. Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells.
Wennerberg E; Pfefferle A; Ekblad L; Yoshimoto Y; Kremer V; Kaminskyy VO; Juhlin CC; Höög A; Bodin I; Svjatoha V; Larsson C; Zedenius J; Wennerberg J; Lundqvist A
Clin Cancer Res; 2014 Nov; 20(22):5733-44. PubMed ID: 25212604
[TBL] [Abstract][Full Text] [Related]
19. NK cell recognition and killing of melanoma cells is controlled by multiple activating receptor-ligand interactions.
Morgado S; Sanchez-Correa B; Casado JG; Duran E; Gayoso I; Labella F; Solana R; Tarazona R
J Innate Immun; 2011; 3(4):365-73. PubMed ID: 21576932
[TBL] [Abstract][Full Text] [Related]
20. Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells.
Coudert JD; Zimmer J; Tomasello E; Cebecauer M; Colonna M; Vivier E; Held W
Blood; 2005 Sep; 106(5):1711-7. PubMed ID: 15886320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]